Research article summary (published 30 Aug 2009):

Aspirin resistance.

Full Abstract

No abstract is currently available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Tantry, Udaya S (US); Mahla, Elisabeth (E); Gurbel, Paul A (PA);

Affiliation: Sinai Center for Thrombosis Research, Baltimore, MD, USA.

Journal and publication information

Publication Type: Journal Article; Review

Journal: Progress in cardiovascular diseases (Prog Cardiovasc Dis), published in United States. (Language: eng)

Reference: -2009 Sep-Oct; vol 52 (issue 2) : pp 141-52

Dates: Created 2009/09/07; Completed 2009/09/18;

PMID: 19732606, status: MEDLINE (last retrieved date: 9/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Aspirin - administration & dosage; pharmacokinetics; pharmacology Blood Platelets - drug effects Cardiovascular Diseases - prevention & control Cyclooxygenase 1 - drug effects; physiology Cyclooxygenase 2 - drug effects; physiology Drug Resistance

Humans Platelet Activation - drug effects; physiology Platelet Aggregation - drug effects; physiology Platelet Aggregation Inhibitors - administration & dosage; pharmacokinetics; pharmacology Thromboxane A2 - metabolism Thromboxane B2 - metabolism

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Platelet Aggregation Inhibitors (0) ; Aspirin (50-78-2) ; Thromboxane B2 (54397-85-2) ; Thromboxane A2 (57576-52-0) ; Cyclooxygenase 1 (EC 1.14.99.1) ; Cyclooxygenase 2 (EC 1.14.99.1)

Related articles

These are the most related articles currently in our database:

• Aspirin resistance: is this term meaningful? 30 Aug 2006
• Laboratory detection of 'aspirin resistance': what test should we use (if any)? 20 Jun 2007
• A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. 12 Jun 2007
• Variability in individual responsiveness to aspirin: clinical implications and treatment. 29 Nov 2007
• Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. 22 Apr 2007
• Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation. 30 Mar 1991
• Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. 29 Jun 2008
• Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation. 30 Oct 2001
• Determinants of the interindividual variability in response to antiplatelet drugs. 30 Jul 2005
• Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. 20 Jun 1999

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.